NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹72 Cr | ₹-68 Cr | ₹9.00 Cr | ₹76 Cr | ₹9.80 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NATCO PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹72 Cr |
| Mar2024 | ₹-68 Cr |
| Mar2023 | ₹9.00 Cr |
| Mar2022 | ₹76 Cr |
| Mar2021 | ₹9.80 Cr |
How is Net Cash Inflow / Outflow of NATCO PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹72 Cr | Positive | |
| Mar2024 | ₹-68 Cr | Negative | |
| Mar2023 | ₹9.00 Cr | -88.16 | |
| Mar2022 | ₹76 Cr | 675.51 | |
| Mar2021 | ₹9.80 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,436.0 Cr | -1.4% | -6.8% | -4.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -1.4% |
-6.8% |
-4.4% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses